newsfilter
← Latest News
GlobeNewswire·

Biophytis Reports H1 2021 Financial Results and Provides Business Update

SARA-INT: Positive top line results of Phase 2 study demonstrate efficacy of Sarconeos (BIO101) in sarcopenia and support progress into Phase 3 COVA: DMC second interim analysis shows efficacy results in the promising zone allowing continuation of the